Q BioMed Inc. reported earnings results for the first quarter ended February 28, 2023. For the first quarter, the company reported net loss was USD 0.721612 million compared to USD 2.29 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.08 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | +20.00% | +20.00% | +50.00% |
2023 | Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023 | CI |
2023 | Q BioMed Inc. Reports Earnings Results for the Full Year Ended November 30, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+50.00% | 72.55K | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- QBIO Stock
- News Q BioMed Inc.
- Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023